NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional)
National Institutes of Health
Free. Verify your email, then we send one reminder only.
- Posted
- Dec 17, 2025
- Closes
- Apr 28, 2027 (in 242 days)
Similar opportunities open now
- NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional)Same funderOpenNational Institutes of HealthCloses Apr 2027
- NIDCD Early Career Research(ECR) Award (R21 Clinical Trial Optional)Same funderOpenNational Institutes of HealthCloses Oct 2027
- NHLBI Program Project Applications (P01 Clinical Trials Optional)Same funderOpenNational Institutes of HealthCloses in 27 days
- Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)Same funderOpenNational Institutes of HealthCloses Jan 2028
- NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)Same funderOpenNational Institutes of HealthCloses Jan 2027
Classification and identifiers
- Solicitation number
- RFA-HL-26-003
- Assistance listing (CFDA)
- 93.233
Amount
Amount not published by the funder
Who can apply
Local government agencies can apply here. Check the eligibility details below to see if your organization fits.
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as ...
About this opportunity
The purpose of the NHLBI Emerging Investigator Award (EIA) is to promote scientific productivity and innovation by providing long-term support and increased flexibility to experienced Program Directors/Principal Investigators (PDs/PIs) who are currently PDs/PIs on at least two NHLBI R01-equivalent awards and whose outstanding record of research demonstrates their ability to make major contributions to heart, lung, blood and sleep (HLBS) research. The EIA is intended to support a research program, rather than a research project, by providing the primary and most likely sole source of NHLBI funding on individual grant awards. The EIA will support the research program of NHLBI-funded investigators for up to seven years. The EIA will provide investigators increased freedom to conduct research ...